236 related articles for article (PubMed ID: 17134739)
41. Clonal proliferation of cyclin D1-positive mantle lymphocytes in an asymptomatic patient: an early-stage event in the development or an indolent form of a mantle cell lymphoma?
Espinet B; Solé F; Pedro C; Garcia M; Bellosillo B; Salido M; Florensa L; Camacho FI; Baró T; Lloreta J; Serrano S
Hum Pathol; 2005 Nov; 36(11):1232-7. PubMed ID: 16260278
[TBL] [Abstract][Full Text] [Related]
42. Marginal zone variant of mantle cell lymphoma: CD5-negative cyclin D1-positive variant posing a diagnostic dilemma.
Golardi N; Velasco MR; Elghetany MT
Pathol Int; 2009 May; 59(5):317-21. PubMed ID: 19432674
[TBL] [Abstract][Full Text] [Related]
43. Derivative (14)t(11;14)(q13;q32)t(11;14)(p11.2;p11.2): a novel unbalanced variant of the t(11;14)(q13;q32) translocation in mantle cell lymphoma.
Sathanoori M; Shekhter-Levin S; Marks SM; Swerdlow SH
Cancer Genet Cytogenet; 2007 Jan; 172(2):158-64. PubMed ID: 17213026
[TBL] [Abstract][Full Text] [Related]
44. Splenic involvement by blastic mantle cell lymphoma (large cell/anaplastic variant) mimicking splenic marginal zone lymphoma.
Mollejo M; Lloret E; Solares J; Bergua JM; Mateo M; Piris MA
Am J Hematol; 1999 Dec; 62(4):242-6. PubMed ID: 10589081
[TBL] [Abstract][Full Text] [Related]
45. [Lymphoma of the splenic mantle. Morphologic, immunologic and ultrastructural characterization of a case].
Sabater Marco V; Alemany Monraval P; Ferrando Marco J; Salvador Villalba I; Martorell Cebollada M
Med Clin (Barc); 1991 Jan; 96(2):63-5. PubMed ID: 2023478
[TBL] [Abstract][Full Text] [Related]
46. The role of cannabinoid receptors and the endocannabinoid system in mantle cell lymphoma and other non-Hodgkin lymphomas.
Wasik AM; Christensson B; Sander B
Semin Cancer Biol; 2011 Nov; 21(5):313-21. PubMed ID: 22024769
[TBL] [Abstract][Full Text] [Related]
47. [Morphological aspects of low-grade B-cell lymphoma].
Berger F; Felman P; Bryon PA
Ann Pathol; 1998 Oct; 18(4):261-75. PubMed ID: 9827219
[No Abstract] [Full Text] [Related]
48. Splenic marginal zone lymphoma.
Dogan A; Isaacson PG
Semin Diagn Pathol; 2003 May; 20(2):121-7. PubMed ID: 12945935
[TBL] [Abstract][Full Text] [Related]
49. Lymphoma of the ocular adnexa: A study of 353 cases.
Ferry JA; Fung CY; Zukerberg L; Lucarelli MJ; Hasserjian RP; Preffer FI; Harris NL
Am J Surg Pathol; 2007 Feb; 31(2):170-84. PubMed ID: 17255761
[TBL] [Abstract][Full Text] [Related]
50. Establishment of the MAVER-1 cell line, a model for leukemic and aggressive mantle cell lymphoma.
Zamò A; Ott G; Katzenberger T; Adam P; Parolini C; Scarpa A; Lestani M; Menestrina F; Chilosi M
Haematologica; 2006 Jan; 91(1):40-7. PubMed ID: 16434369
[TBL] [Abstract][Full Text] [Related]
51. Splenic fine needle aspiration biopsy in the diagnosis of lymphoreticular diseases. A report of four cases.
Moriarty AT; Schwenk GR; Chua G
Acta Cytol; 1993; 37(2):191-6. PubMed ID: 8465640
[TBL] [Abstract][Full Text] [Related]
52. Rearrangement of the RHOH gene in a case of splenic lymphoma with villous lymphocytes.
Bernicot I; Morel F; Le Bris MJ; Bail JP; Douet-Guilbert N; De Braekeleer M
Cancer Genet Cytogenet; 2006 Oct; 170(1):78-9. PubMed ID: 16965962
[No Abstract] [Full Text] [Related]
53. Coexistence of two discordant B-cell lymphomas in the skin and lymph node: report of a case with primary cutaneous follicle-center lymphoma and nodal mantle-cell lymphoma.
Goteri G; Rupoli S; Stramazzotti D; Discepoli G; Scortechini AR; Giacchetti A; Morichetti D; Tassetti A; Pulini S; Mulattieri S; Stronati A; Leoni P
Br J Dermatol; 2007 Sep; 157(3):629-31. PubMed ID: 17596170
[No Abstract] [Full Text] [Related]
54. Splenic follicular lymphoma: clinicopathologic characteristics of a series of 32 cases.
Mollejo M; Rodríguez-Pinilla MS; Montes-Moreno S; Algara P; Dogan A; Cigudosa JC; Juarez R; Flores T; Forteza J; Arribas A; Piris MA
Am J Surg Pathol; 2009 May; 33(5):730-8. PubMed ID: 19194277
[TBL] [Abstract][Full Text] [Related]
55. Comparative genome profiling across subtypes of low-grade B-cell lymphoma identifies type-specific and common aberrations that target genes with a role in B-cell neoplasia.
Ferreira BI; García JF; Suela J; Mollejo M; Camacho FI; Carro A; Montes S; Piris MA; Cigudosa JC
Haematologica; 2008 May; 93(5):670-9. PubMed ID: 18367492
[TBL] [Abstract][Full Text] [Related]
56. Molecular heterogeneity of splenic marginal zone lymphomas: analysis of mutations in the 5' non-coding region of the bcl-6 gene.
Mateo MS; Mollejo M; Villuendas R; Algara P; Sanchez-Beato M; Martínez P; Piris MA
Leukemia; 2001 Apr; 15(4):628-34. PubMed ID: 11368366
[TBL] [Abstract][Full Text] [Related]
57. Immunophenotypic Characterization of Canine Splenic Follicular-Derived B-Cell Lymphoma.
Stein L; Bacmeister C; Ylaya K; Fetsch P; Wang Z; Hewitt SM; Kiupel M
Vet Pathol; 2019 May; 56(3):350-357. PubMed ID: 30636524
[TBL] [Abstract][Full Text] [Related]
58. Burkitt lymphoma following splenic marginal zone lymphoma. evidence for two independent B-cell clones.
Heintel D; Streubel B; Welzel N; Le T; Schwarzinger I; Haas OA; Simonitsch I; Lechner K; Jaeger U
Cancer Genet Cytogenet; 2003 Feb; 141(1):86-8. PubMed ID: 12581905
[TBL] [Abstract][Full Text] [Related]
59. Splenic marginal zone lymphoma with micronodular T-cell rich B-cell lymphoma.
Wang SA; Olson N; Zukerberg L; Harris NL
Am J Surg Pathol; 2006 Jan; 30(1):128-32. PubMed ID: 16330953
[TBL] [Abstract][Full Text] [Related]
60. Simultaneous presence of t(2;8)(p12;q24) and t(14;18)(q32;q21) in a B-cell lymphoproliferative disorder with features suggestive of an aggressive variant of splenic marginal-zone lymphoma.
Batanian JR; Dunphy CH; Richart JM; Petruska PJ; Perkins SL
Cancer Genet Cytogenet; 2000 Jul; 120(2):136-40. PubMed ID: 10942804
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
